Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2015

01.01.2015 | Preclinical study

Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated

verfasst von: Mitra Noroozian, Lauren F. Stein, Kara Gaetke-Udager, Mark A. Helvie

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the study was to determine the long-term clinical outcomes of women with breast pain in the absence of additional symptoms or signs (isolated breast pain), and the utility of mammography in their work-up. IRB approved, HIPAA compliant study retrospectively reviewed 1,386 patients referred for breast imaging with ICD-9 code for breast pain between 1/1/2006 and 12/31/2007. Of these, 617 consecutive women (mean age, 49 years) with isolated breast pain, mammogram, and follow-up (mean, 51 months) constituted the study group. Clinical data, mammographic and sonographic BI-RADS assessments, and geographic relationship between the site of cancer and pain were evaluated. The frequency of malignancies and of specific benign outcomes, both at and subsequent to the time of presentation, was determined. Breast cancer and specific benign outcomes were diagnosed in the painful breast of 11/617 (1.8 %) and 63/617 (10.2 %) women, respectively. Majority of the cancers (9/11, 81.8 %) were diagnosed subsequent (5–52 months) to initial imaging evaluation, whereas the majority of benign outcomes (52/63, 82.5 %) were diagnosed at initial presentation. Diagnostic mammography at initial presentation had a negative predictive value of 99.8 % (95 % CI 99.1 %, 100 %), specificity of 98.5 % (95 % CI 97.2 %, 99.3 %), and sensitivity of 66.7 % (95 % CI 11.6 %, 94.5 %). Three cancers were subsequently diagnosed in the contralateral (non-painful) breast. Eleven of 14 (78.6 %) cancers were in the symptomatic breast, of which 9 (81.8 %) geographically corresponded to the same area of focal pain. Thus, infrequently,  breast cancer may clinically present as or be preceded by isolated breast pain and diagnostic mammography is useful for assessment.
Literatur
1.
Zurück zum Zitat Barton MB, Elmore JG, Fletcher SW (1999) Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med 130(8):651–657PubMedCrossRef Barton MB, Elmore JG, Fletcher SW (1999) Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med 130(8):651–657PubMedCrossRef
2.
Zurück zum Zitat Smith RL, Pruthi S, Fitzpatrick LA (2004) Evaluation and management of breast pain. Mayo Clin Proc 79(3):353–372PubMedCrossRef Smith RL, Pruthi S, Fitzpatrick LA (2004) Evaluation and management of breast pain. Mayo Clin Proc 79(3):353–372PubMedCrossRef
3.
Zurück zum Zitat Conry C (1994) Evaluation of a breast complaint: is it cancer? Am Fam Physician 49(2):445–450, 453–444PubMed Conry C (1994) Evaluation of a breast complaint: is it cancer? Am Fam Physician 49(2):445–450, 453–444PubMed
4.
Zurück zum Zitat Duijm LE, Guit GL, Hendriks JH, Zaat JO, Mali WP (1998) Value of breast imaging in women with painful breasts: observational follow up study. BMJ 317(7171):1492–1495PubMedCentralPubMedCrossRef Duijm LE, Guit GL, Hendriks JH, Zaat JO, Mali WP (1998) Value of breast imaging in women with painful breasts: observational follow up study. BMJ 317(7171):1492–1495PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Leung JW, Kornguth PJ, Gotway MB (2002) Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 21(5):521–526, quiz 528-529PubMed Leung JW, Kornguth PJ, Gotway MB (2002) Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 21(5):521–526, quiz 528-529PubMed
6.
Zurück zum Zitat Preece PE, Baum M, Mansel RE, Webster DJ, Fortt RW, Gravelle IH, Hughes LE (1982) Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) 284(6325):1299–1300CrossRef Preece PE, Baum M, Mansel RE, Webster DJ, Fortt RW, Gravelle IH, Hughes LE (1982) Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) 284(6325):1299–1300CrossRef
8.
Zurück zum Zitat Jumah KB, Obajimi MO, Darko R (2003) Women with painful breasts without palpable masses: do they really need a mammogram? Afr J Med Med Sci 32(4):387–389PubMed Jumah KB, Obajimi MO, Darko R (2003) Women with painful breasts without palpable masses: do they really need a mammogram? Afr J Med Med Sci 32(4):387–389PubMed
9.
Zurück zum Zitat Lumachi F, Ermani M, Brandes AA, Boccagni P, Polistina F, Basso SM, Favia G, D’Amico DF (2002) Breast complaints and risk of breast cancer. Population-based study of 2,879 self-selected women and long-term follow-up. Biomed Pharmacother 56(2):88–92PubMedCrossRef Lumachi F, Ermani M, Brandes AA, Boccagni P, Polistina F, Basso SM, Favia G, D’Amico DF (2002) Breast complaints and risk of breast cancer. Population-based study of 2,879 self-selected women and long-term follow-up. Biomed Pharmacother 56(2):88–92PubMedCrossRef
10.
Zurück zum Zitat Leddy R, Irshad A, Zerwas E, Mayes N, Armeson K, Abid M, Cluver A, Campbell A, Ackerman S, Lewis M (2013) Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast J 19(6):582–589. doi:10.1111/tbj.12178 PubMedCrossRef Leddy R, Irshad A, Zerwas E, Mayes N, Armeson K, Abid M, Cluver A, Campbell A, Ackerman S, Lewis M (2013) Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast J 19(6):582–589. doi:10.​1111/​tbj.​12178 PubMedCrossRef
11.
Zurück zum Zitat Mansel RE (2010) Management of Breast Pain. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast. 4th edn. Lippincott Williams & Wilkins, a Wolters Kluwer business Philadelphia 52–57 Mansel RE (2010) Management of Breast Pain. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast. 4th edn. Lippincott Williams & Wilkins, a Wolters Kluwer business Philadelphia 52–57
12.
Zurück zum Zitat D’Orsi CJ, Bassett LW, Berg WA, Feig SA, Jackson VP, Kopans DB, Linver MN, Mendelson EB, Moss LJ, Sickles EA (2003) American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS®). Breast imaging atlas, 4th edn. American College of Radiology, Reston D’Orsi CJ, Bassett LW, Berg WA, Feig SA, Jackson VP, Kopans DB, Linver MN, Mendelson EB, Moss LJ, Sickles EA (2003) American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS®). Breast imaging atlas, 4th edn. American College of Radiology, Reston
13.
Zurück zum Zitat Masroor I, Afzal S, Sakhawat S, Khan N, Beg MA, Kawal D (2009) Negative predictive value of mammography and sonography in mastalgia with negative physical findings. J Pak Med Assoc 59(9):598–601PubMed Masroor I, Afzal S, Sakhawat S, Khan N, Beg MA, Kawal D (2009) Negative predictive value of mammography and sonography in mastalgia with negative physical findings. J Pak Med Assoc 59(9):598–601PubMed
14.
Zurück zum Zitat American College of Radiology (ACR) (2011) American College of Radiology practice guidelines and technical standards: practice guidelines for performance of screening and diagnostic mammography. http://www.acr.org/guidelines. Accessed 20 Dec 2011 American College of Radiology (ACR) (2011) American College of Radiology practice guidelines and technical standards: practice guidelines for performance of screening and diagnostic mammography. http://​www.​acr.​org/​guidelines. Accessed 20 Dec 2011
Metadaten
Titel
Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated
verfasst von
Mitra Noroozian
Lauren F. Stein
Kara Gaetke-Udager
Mark A. Helvie
Publikationsdatum
01.01.2015
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3257-3

Weitere Artikel der Ausgabe 2/2015

Breast Cancer Research and Treatment 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.